Astria Therapeutics, Inc. (ATXS)
USD 5.36
(3.88%)
USD 5.36
(3.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -68.44 Million | -43.53 Million | -30.15 Million | -32.48 Million | -26.56 Million | -23.46 Million |
| Net Income | -72.89 Million | -51.83 Million | -194.91 Million | -37.3 Million | -26.29 Million | -25.87 Million |
| Depreciation & Amortization | - | - | - | - | 26 Thousand | 119 Thousand |
| Deferred income taxes | - | - | - | - | 23 Thousand | -303 Thousand |
| Stock-based compensation | 6.31 Million | 4.55 Million | 3.36 Million | 1.39 Million | 1.51 Million | 1.77 Million |
| Change in working capital | -2.41 Million | 2.64 Million | -3.3 Million | 3.36 Million | -1.87 Million | 762 Thousand |
| Other non-cash items | 545 Thousand | 1.1 Million | 164.7 Million | 58 Thousand | 33 Thousand | 56 Thousand |
| Investing Cash Flow | 135.05 Million | -167.12 Million | -12.55 Million | 6.3 Million | -4.08 Million | -21.9 Million |
| Investments in PPE | -25 Thousand | -91 Thousand | -21 Thousand | -33 Thousand | -12 Thousand | 18 Thousand |
| Acquisitions | - | 167.03 Thousand | 6.46 Million | -6333.00 | 4070.00 | -18 Thousand |
| Investment purchases | -1.92 Billion | -396.06 Million | -78 Million | -62.77 Million | -155.19 Million | -70.36 Million |
| Sales/Maturities of investments | 2.05 Billion | 229.02 Million | 59 Million | 69.11 Million | 151.12 Million | 48.09 Million |
| Other Investing Activities | 135.07 Thousand | -167.03 Thousand | -12.53 Thousand | 6333.00 | -4070.00 | 369 Thousand |
| Financing Cash Flow | 88.39 Million | 144.72 Million | 104.28 Million | 40.86 Million | 25.62 Million | 44.29 Million |
| Debt repayment | - | - | - | - | - | -2.84 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 88.39 Million | 144.63 Million | 104.28 Million | 40.82 Million | 25.56 Million | 47.13 Million |
| Other Financing Activities | 88.39 Million | 84 Thousand | 104.28 Million | 31 Thousand | 54 Thousand | 4000.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 725 Thousand | -766 Thousand | -1.96 Million | 347 Thousand | -211 Thousand | 662 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.13 Million | 3.41 Million | -1.34 Million | 3.02 Million | -1.65 Million | 100 Thousand |
| Cash at beginning of period | 20.68 Million | 86.62 Million | 25.05 Million | 10.37 Million | 15.4 Million | 16.48 Million |
| Cash at end of period | 175.69 Million | 20.68 Million | 86.62 Million | 25.05 Million | 10.37 Million | 15.4 Million |
| Capital Expenditure | -25 Thousand | -91 Thousand | -21 Thousand | -33 Thousand | -12 Thousand | 18 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 155 Million | -65.94 Million | 61.57 Million | 14.67 Million | -5.03 Million | -1.07 Million |
| Free Cash Flow | -68.47 Million | -43.62 Million | -30.17 Million | -32.51 Million | -26.58 Million | -23.44 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.17 Million | -19.92 Million | -31.41 Million | -72.89 Million | -17.72 Million | -12.56 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3.45 Million | 2.75 Million | 2.06 Million | 6.31 Million | 1.69 Million | 1.33 Million |
| Change in working capital | 5.49 Million | -1.4 Million | -1.06 Million | -2.41 Million | 1.61 Million | 432 Thousand |
| Other non-cash items | 409 Thousand | 2.89 Million | 163 Thousand | 545 Thousand | 159 Thousand | 107 Thousand |
| Investing Cash Flow | -68.1 Million | -126.23 Million | -2.01 Million | 135.05 Million | -4000.00 | -57.92 Million |
| Investments in PPE | -305 Thousand | - | -16 Thousand | -25 Thousand | -4000.00 | - |
| Acquisitions | - | - | 194.99 Thousand | - | - | - |
| Investment purchases | -1.38 Billion | -1.04 Billion | -708 Million | -1.92 Billion | -913.5 Million | -207 Million |
| Sales/Maturities of investments | 1.32 Billion | 923 Million | 706 Million | 2.05 Billion | 913.5 Million | 149.08 Million |
| Other Investing Activities | -67.79 Thousand | -126.23 Thousand | -2000.00 | 135.07 Thousand | - | -57.92 Thousand |
| Financing Cash Flow | 94 Thousand | 141.8 Million | 87.97 Million | 88.39 Million | 110 Thousand | 273 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 94 Thousand | 141.8 Million | 87.97 Million | 88.39 Million | 110 Thousand | 273 Thousand |
| Other Financing Activities | 94.00 | 141.8 Thousand | 87.97 Thousand | 88.39 Million | 110.00 | 273.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.47 Million | -651 Thousand | 375 Thousand | 725 Thousand | 309 Thousand | -99 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.01 Million | -757 Thousand | -1.43 Million | -3.13 Million | 1.3 Million | 531 Thousand |
| Cash at beginning of period | 172.17 Million | 175.69 Million | 119.96 Million | 20.68 Million | 134.12 Million | 202.46 Million |
| Cash at end of period | 87.37 Million | 172.17 Million | 175.69 Million | 175.69 Million | 119.96 Million | 134.12 Million |
| Capital Expenditure | -305 Thousand | - | -16 Thousand | -25 Thousand | -4000.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -84.8 Million | -3.51 Million | 55.72 Million | 155 Million | -14.15 Million | -68.34 Million |
| Free Cash Flow | -17.09 Million | -19.09 Million | -30.25 Million | -68.47 Million | -14.26 Million | -10.69 Million |
CWR
TH1NG
600328
ALLEX
BRK-B
9501